Please check your internet connection and try again.
# Meftal Spas
## Overview
Meftal Spas is a combination product containing mefenamic acid (a nonsteroidal anti-inflammatory drug, NSAID) and dicyclomine hydrochloride (an anticholinergic antispasmodic).
## Primary Indications
* Symptomatic relief of mild to moderate pain associated with smooth muscle spasms, particularly in gynecological conditions (e.g., dysmenorrhea) and gastrointestinal disorders.
## Adult Dosing
* **Meftal Spas Tablet:** Typically 1 tablet (containing mefenamic acid 250 mg and dicyclomine HCl 10 mg) every 8 hours as needed.
* **Maximum Dosing:** Consult local prescribing information for specific maximum daily doses for each component, but generally avoid exceeding recommended NSAID or anticholinergic limits.
## Pediatric Dosing
* The use of Meftal Spas in pediatric patients is generally **not recommended** due to lack of established safety and efficacy data. Mefenamic acid dosing in children over 6 months is typically weight-based (e.g., 5-7 mg/kg/dose every 6-8 hours). Dicyclomine use in children requires careful consideration and is often dosed based on weight, but specific Meftal Spas formulations are not typically indicated.
## Dose Adjustments
* **Renal Impairment:** Mefenamic acid should be used with caution in patients with renal impairment. Dose reduction may be necessary, or alternative analgesics considered.
* **Hepatic Impairment:** Mefenamic acid should be used with caution in patients with hepatic impairment. Monitor liver function closely.
* **Elderly:** Elderly patients may be at increased risk of adverse effects from NSAIDs, including gastrointestinal bleeding, renal impairment, and cardiovascular events. Use with caution and consider lower doses.
## Contraindications
* Known hypersensitivity to mefenamic acid, dicyclomine, or other NSAIDs.
* History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
* Active gastrointestinal bleeding or perforation.
* Inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis).
* Severe heart failure.
* Severe renal or hepatic impairment.
* Glaucoma (relative contraindication for dicyclomine).
* Obstructive uropathy or gastrointestinal obstruction (relative contraindication for dicyclomine).
* Myasthenia gravis (relative contraindication for dicyclomine).
* Infants < 6 months of age (for dicyclomine due to risk of respiratory depression).
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, constipation, abdominal pain, dizziness, headache, dry mouth, blurred vision.
* **Serious:**
* **Mefenamic Acid:** Gastrointestinal bleeding, ulceration, perforation; renal toxicity; hepatic toxicity; cardiovascular thrombotic events; hypersensitivity reactions; Stevens-Johnson syndrome/toxic epidermal necrolysis.
* **Dicyclomine:** Anticholinergic effects (urinary retention, constipation, confusion, blurred vision, tachycardia); exacerbation of glaucoma; respiratory depression (especially in infants).
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin):** Increased risk of bleeding with mefenamic acid.
* **Corticosteroids:** Increased risk of gastrointestinal ulceration and bleeding.
* **Other NSAIDs/Aspirin:** Increased risk of gastrointestinal toxicity and renal impairment.
* **ACE Inhibitors/ARBs/Diuretics:** NSAIDs can reduce their antihypertensive and diuretic effects and increase the risk of renal impairment.
* **Lithium/Methotrexate:** NSAIDs can increase serum levels of these drugs.
* **Anticholinergics (e.g., tricyclic antidepressants, antihistamines):** Additive anticholinergic effects with dicyclomine.
* **Antacids:** May decrease absorption of dicyclomine.
## Monitoring
* **Gastrointestinal:** Monitor for signs and symptoms of gastrointestinal bleeding (e.g., melena, hematemesis).
* **Renal Function:** Periodic monitoring of renal function, especially in patients with pre-existing renal disease or those on concomitant nephrotoxic agents.
* **Hepatic Function:** Periodic monitoring of liver function tests, especially in patients with liver disease.
* **Blood Pressure:** Monitor blood pressure, especially during the initiation of NSAID therapy.
* **Signs of Anticholinergic Effects:** Monitor for dry mouth, blurred vision, urinary retention, constipation, and confusion.
## Clinical Pearls
* Meftal Spas should be used at the lowest effective dose for the shortest duration necessary to minimize risks.
* Administer with food or milk to reduce gastrointestinal upset.
* Patients should be advised to avoid concomitant use of other NSAIDs or alcohol.
* Dicyclomine's anticholinergic effects can impair cognitive and motor skills; caution patients regarding activities requiring alertness.
* Consider alternatives for patients with a history of peptic ulcer disease or other contraindications to NSAIDs.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and your healthcare provider before making any decisions about medication. Dosing and safety information may vary by region and specific product formulation.
